London-based personalised nutrition startup Zoe has received a $2.5 million investment from recent VC world entry Flight Fund. According to the company, the additional capital will be used to further scale operations.
Putting the commercial play aside for a moment, Zoe is fusing tech with collaborations with leading scientists around the world, resulting in the ongoing PREDICT programme, a global nutritional research initiative, and an 800,000-person observational study to measure the accuracy of its AI diagnostic for COVID-19.
Based on results uncovered in the PREDICT programme, Zoe’s personalised nutrition offer begins with at-home tests that analyse blood sugar, blood fat responses, and the gut microbiome.